A pilot open study of long term high dose creatine augmentation in patients with treatment resistant negative symptoms schizophrenia.

CONCLUSION: This small, open design study of high dose creatine add-on for 6 months in chronic inpatients with schizophrenia demonstrated only mild positive effects on the patients' symptomatology and behavior and might have beneficial effect on tardive parkinsonism. PMID: 25841104 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25841104?dopt=Abstract

Source: Israel Journal of Psychiatry and Related Sciences - June 4, 2015 Category: Psychiatry Tags: Isr J Psychiatry Relat Sci Source Type: research